Birmingham Capital Management CO Inc/Al Abbott Laboratories Transaction History

Birmingham Capital Management CO Inc/Al

$274 Million
Q3 2024

A detailed history of Birmingham Capital Management CO Inc/Al transactions in Abbott Laboratories stock. As of the latest transaction made, Birmingham Capital Management CO Inc/Al holds 24,680 shares of ABT stock, worth $2.8 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares

24,680

Previous 24,680 -0.0%

Holding current value

$2.8 Million

Previous $2.56 Million 9.71%

% of portfolio

1.03%

Previous 1.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 28, 2024	SELL	$100.73 - $112.44 $20,146 - $22,488	-200 Reduced 0.8%	24,680 $2.56 Million
Q1 2024 May 29, 2024	SELL	$109.52 - $120.96 $21,904 - $24,192	-200 Reduced 0.8%	24,880 $2.83 Million
Q4 2023 Feb 20, 2024	SELL	$90.19 - $110.4 $54,114 - $66,240	-600 Reduced 2.34%	25,080 $2.76 Million
Q3 2023 Dec 13, 2023	BUY	$95.53 - $114.62 $152,848 - $183,392	1,600 Added 6.64%	25,680 $2.49 Million
Q2 2023 Sep 19, 2023	SELL	$100.78 - $112.29 $161,248 - $179,664	-1,600 Reduced 6.23%	24,080 $2.63 Million
Q1 2022 Apr 29, 2022	SELL	$114.02 - $139.04 $79,814 - $97,328	-700 Reduced 2.65%	25,680 $3.04 Million
Q1 2021 Apr 30, 2021	SELL	$108.84 - $128.23 $11,972 - $14,105	-110 Reduced 0.42%	26,380 $3.16 Million
Q4 2020 Feb 03, 2021	SELL	$105.0 - $114.42 $52,500 - $57,210	-500 Reduced 1.85%	26,490 $2.9 Million
Q3 2020 Oct 30, 2020	SELL	$91.64 - $111.29 $31,615 - $38,395	-345 Reduced 1.26%	26,990 $2.94 Million
Q1 2020 Apr 28, 2020	SELL	$62.82 - $91.86 $94,230 - $137,790	-1,500 Reduced 5.2%	27,335 $2.16 Million
Q4 2019 Feb 03, 2020	SELL	$78.51 - $87.4 $19,627 - $21,850	-250 Reduced 0.86%	28,835 $2.51 Million
Q3 2019 Nov 05, 2019	SELL	$81.84 - $88.74 $143,220 - $155,295	-1,750 Reduced 5.68%	29,085 $2.43 Million
Q4 2018 Jan 30, 2019	SELL	$65.56 - $74.27 $8,391 - $9,506	-128 Reduced 0.41%	30,835 $2.23 Million
Q3 2018 Nov 19, 2018	SELL	$60.81 - $73.36 $41,046 - $49,518	-675 Reduced 2.13%	30,963 $2.27 Million
Q2 2018 Jul 20, 2018	SELL	$57.57 - $63.54 $46,056 - $50,832	-800 Reduced 2.47%	31,638 $1.93 Million
Q1 2018 Apr 24, 2018	SELL	$56.27 - $63.62 $5,964 - $6,743	-106 Reduced 0.33%	32,438 $1.94 Million
Q4 2017 Feb 08, 2018	BUY	$53.68 - $57.47 $1.75 Million - $1.87 Million	32,544	32,544 $1.86 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Birmingham Capital Management CO Inc/Al, based on Form 13F filings with the SEC.

News

Stay updated on Birmingham Capital Management CO Inc/Al with notifications on news.

Account

Birmingham Capital Management CO Inc/Al Abbott Laboratories Transaction History